NORD · OTC
The quarter ending March 31, 2025, against the same quarter a year earlier.
| Measure | 3 months toMar 31, 2025 | 3 months toJun 30, 2019 | Change |
|---|---|---|---|
| Total Revenue | $0.00 | $864.00 | -100.00% |
| Profit | -$2.3M | -$1.2M | -88.61% |
| Profit per share | -$0.13 | -$0.07 | -85.71% |
| Free Cash Flow | -$168.6K | $289K | -158.35% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Nordicus Partners Corporation has no earnings call transcript available.
“The decrease in our fiscal 2011 third quarter product sales was largely attributable to decreased demand for polymers from two significant customers,”
Quoted verbatim from the release, and shown only when the filing attributes it to a named person.
AdvanSource Biomaterials Corporation manufactures advanced polymer materials which provide critical characteristics in the design and development of medical devices. The Company’s biomaterials are used in devices that are designed for treating a broad range of anatomical sites and disease states. AdvanSource’s business model leverages its proprietary materials science technology and manufacturing expertise in order to expand its product sales and royalty and license fee income. More information about AdvanSource is available at its website: www.advbiomaterials.com .
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from Nordicus Partners Corporation’s Item 2.02 8-K filed February 18, 2011; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.